The interleukin-4 receptor (IL-4R) is emerging as a potential drug target, projected to potentially be worth up to 10 billion USD. In this article, ACROBiosystems discusses why it is such an attractive drug target and what this could entail.
/PRNewswire/ The "Growth Opportunities in AI for Drug Target Discovery and Validation" report has been added to ResearchAndMarkets.com s offering. The score.
DUBLIN (BUSINESS WIRE) The "Growth Opportunities in AI for Drug Target Discovery and Validation" report has been added to ResearchAndMarkets.com's offering.The score provided by the AI algorithms is responsible for the prioritization of the drug target. High-score targets are more likely to be considered for furth.